Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.54 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 4/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.41 |
| ▸ | NPC1 | O15118 | 3/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | FAAH | O00519 | 1/20 | 0.37 |
| ▸ | CTSK | P43235 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | CTSA | P10619 | 1/20 | 0.36 |
| ▸ | CASP1 | P29466 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | PTPRB | P23467 | 1/20 | 0.36 |
| ▸ | AGTR2 | P50052 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6207417 | 0.89 | L3MBTL1 (0.55) | L3MBTL1PKMRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL4385673 | 0.74 | SMN1; SMN2 (0.51) | L3MBTL1RAB9ASMN1; SMN2NPC1MAPK1 | |
| SCHEMBL1721285 | 0.73 | FAAH (0.47) | L3MBTL1RAB9ASMN1; SMN2NPC1MAPK1 | |
| SCHEMBL5201374 | 0.73 | L3MBTL1 (0.55) | L3MBTL1PKMRAB9ASMN1; SMN2MAPK1 | |
| SCHEMBL4096169 | 0.72 | POLB (0.51) | L3MBTL1RAB9ASMN1; SMN2NPC1MAPK1 | |
| SCHEMBL3821977 | 0.71 | MAPT (0.49) | L3MBTL1PKMRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL2345224 | 0.71 | EPHX1 (0.42) | L3MBTL1RAB9ASMN1; SMN2NPC1MAPK1 | |
| SCHEMBL11060290 | 0.71 | EPHX1 (0.44) | L3MBTL1RAB9ASMN1; SMN2NPC1MAPK1 | |
| SCHEMBL10809546 | 0.71 | L3MBTL1 (1.00) | L3MBTL1PKMRAB9ASMN1; SMN2NPC1 | |
| SCHEMBL6207414 | 0.71 | L3MBTL1 (0.55) | L3MBTL1PKMRAB9ASMN1; SMN2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1817275-A1 | HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | Schering Aktiengesellschaft (DE) | 2007-08-15 | — | — | EP | disclosed |
| WO-2006060494-A1 | HALOALKYL CONTAINING COMPOUNDS AS CYSTEINE PROTEASE INHIBITORS | SCHERING AKTIENGESELLSCHAFT (DE) | 2006-06-08 | — | — | WO | disclosed |